23 August 2017Americas

AstraZeneca signs €25m deal to help tackle respiratory disease

German therapeutics developer Ethris has agreed a €25 million ($29 million) research deal with AstraZeneca focused on developing therapies for respiratory diseases.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk